Further investigation into centralized consensus designs targeting other NA subtypes, such as N2, will allow for the delivery of a multivalent NA-targeting vaccine that could show even broader cross-protection from influenza strains of multiple subtypes and across host species. This evidence concerns the gene XK and influenza.